| 0.2 |
0.6 |
GO:1903567 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.1 |
0.4 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.1 |
0.3 |
GO:0061534 |
gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.1 |
0.2 |
GO:0042245 |
RNA repair(GO:0042245) |
| 0.0 |
0.1 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.0 |
0.2 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 0.0 |
0.2 |
GO:0060301 |
vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.0 |
0.2 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.0 |
0.1 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.0 |
0.3 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 |
0.1 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 0.0 |
0.1 |
GO:0036343 |
psychomotor behavior(GO:0036343) |
| 0.0 |
0.1 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 |
0.1 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.0 |
0.2 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 |
0.1 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.0 |
0.3 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 |
0.1 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.0 |
0.4 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
0.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.0 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.0 |
0.3 |
GO:0035745 |
T-helper 2 cell cytokine production(GO:0035745) |
| 0.0 |
0.1 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.0 |
0.0 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 0.0 |
0.0 |
GO:0072302 |
negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.0 |
0.1 |
GO:1901189 |
positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |